410 Medical has raised $12 million in an oversubscribed financing round led by Orlando Health Ventures to accelerate commercial expansion and support the launch of its next-generation LifeFlow infuser.
The round included participation from Hatteras Venture Partners, Ballad Health, OSF Healthcare, Rex Health Ventures, CU Healthcare Innovations Fund, Sarnova, Catalyst by Wellstar, Tampa General, and an undisclosed strategic investor.
Related: CurifyLabs raises $14M Series A to expand personalized medicine platform
The funding will be used to expand commercial operations, increase adoption of the LifeFlow platform, and advance development of the company’s next-generation infuser, which is planned for launch in 2027.
LifeFlow is designed to enable rapid delivery of fluids and blood for patients experiencing sepsis, hemorrhagic shock, and other life-threatening conditions. The platform is currently used by more than 500 hospitals and EMS agencies across the U.S., with nearly 80,000 patients treated to date.
CEO Kyle Chenet said:
“With this funding, we’re able to expand our commercial reach, bringing LifeFlow to more clinicians and investing in the next generation of our technology.”
The financing strengthens 410 Medical’s commercial growth strategy while supporting continued innovation in emergency and critical care resuscitation technologies.
